Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative therapies work by mimicking the inherent actions of GLP-1, a hormone released by the https://kianalzrb007886.blogdigy.com/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes-60892063